Search Results

There are 23720 results for: content related to: Colony-stimulating factors

  1. Infections in pediatric and adolescent oncology

    Evidence-Based Pediatric Oncology

    Ananth Shankar, Sara Stoneham, Pages: 243–267, 2013

    Published Online : 8 MAY 2013, DOI: 10.1002/9781118625309.ch26

  2. You have full text access to this OnlineOpen article
    Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain – results of the LEARN Study

    European Journal of Cancer Care

    Volume 18, Issue 3, May 2009, Pages: 280–286, D. ALMENAR, J. MAYANS, O. JUAN, J.M. GARCIA BUENO, J.I. JALON LOPEZ, A. FRAU, M. GUINOT, P. CEREZUELA, E. GARCIA BUSCALLA, J.A. GASQUET and J. SANCHEZ

    Version of Record online : 8 DEC 2008, DOI: 10.1111/j.1365-2354.2008.00959.x

  3. You have full text access to this OnlineOpen article
    Effectiveness of daily versus non-daily granulocyte colony-stimulating factors in patients with solid tumours undergoing chemotherapy: a multivariate analysis of data from current practice

    European Journal of Cancer Care

    Volume 22, Issue 3, May 2013, Pages: 400–412, D. Almenar Cubells, C. Bosch Roig, E. Jiménez Orozco, R. Álvarez, J.M. Cuervo, N. Díaz Fernández, A.B. Sánchez Heras, A. Galán Brotons, V. Giner Marco, M. Codes M. De Villena and on behalf of LEARN II Study Group

    Version of Record online : 18 JAN 2013, DOI: 10.1111/ecc.12043

  4. Clinical Outcomes and Cost-effectiveness of Primary Prophylaxis of Febrile Neutropenia During Adjuvant Docetaxel and Cyclophosphamide Chemotherapy for Breast Cancer

    The Breast Journal

    Volume 21, Issue 6, November/December 2015, Pages: 658–664, Joanne L. Yu, Kelvin Chan, Michael Kurin, Mark Pasetka, Alex Kiss, Srikala S. Sridhar and Ellen Warner

    Version of Record online : 20 SEP 2015, DOI: 10.1111/tbj.12501

  5. Differential sensitivity of lipegfilgrastim and pegfilgrastim to neutrophil elastase correlates with differences in clinical pharmacokinetic profile

    The Journal of Clinical Pharmacology

    Volume 56, Issue 2, February 2016, Pages: 186–194, Afsaneh Abdolzade-Bavil, Aaron von Kerczek, Bridget A. Cooksey, Thomas Kaufman, Philip A. Krasney, Laurie Pukac, Matthias Görlach, Andreas Lammerich, Christian Scheckermann, Hermann Allgaier, Wenyan David Shen and Patrick M. Liu

    Version of Record online : 1 SEP 2015, DOI: 10.1002/jcph.578

  6. Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony-stimulating factor derivative Maxy-G34 and pegfilgrastim in rats

    Cell Proliferation

    Volume 42, Issue 6, December 2009, Pages: 823–837, M. Scholz, C. Engel, D. Apt, S. L. Sankar, E. Goldstein and M. Loeffler

    Version of Record online : 24 SEP 2009, DOI: 10.1111/j.1365-2184.2009.00641.x

  7. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma

    Intervention Review

    The Cochrane Library

    Julia Bohlius, Christine Herbst, Marcel Reiser, Guido Schwarzer and Andreas Engert

    Published Online : 8 OCT 2008, DOI: 10.1002/14651858.CD003189.pub4

  8. Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients

    Transfusion

    Volume 54, Issue 5, May 2014, Pages: 1243–1250, Ville Varmavuo, Johanna Rimpiläinen, Hanne Kuitunen, Anne Nihtinen, Kaija Vasala, Maija Mikkola, Anu Kutila, Päivi Lehtonen, Taru Kuittinen, Pentti Mäntymaa, Tapio Nousiainen, Outi Kuittinen and Esa Jantunen

    Version of Record online : 30 SEP 2013, DOI: 10.1111/trf.12434

  9. A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma

    Transfusion

    Volume 46, Issue 2, February 2006, Pages: 180–185, Ingmar Bruns, Ulrich Steidl, Ralf Kronenwett, Roland Fenk, Thorsten Graef, Ulrich-Peter Rohr, Frank Neumann, Johannes Fischer, Christof Scheid, Kai Hübel, Rainer Haas and Guido Kobbe

    Version of Record online : 2 DEC 2005, DOI: 10.1111/j.1537-2995.2006.00699.x

  10. Mobilization of Autologous Peripheral Blood Hematopoietic Cells for Cellular Therapy

    Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition

    Thomas C. Shea, John F. DiPersio, Pages: 590–604, 2009

    Published Online : 5 MAR 2009, DOI: 10.1002/9781444303537.ch41

  11. Use of Recombinant Growth Factors after Hematopoietic Cell Transplantation

    Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition

    Jürgen Finke, Roland Mertelsmann, Pages: 645–656, 2009

    Published Online : 5 MAR 2009, DOI: 10.1002/9781444303537.ch45

  12. Neutropenia-Associated Outcomes in Adults with Acute Myeloid Leukemia Receiving Cytarabine Consolidation Chemotherapy with or without Granulocyte Colony-Stimulating Factor

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 12, December 2012, Pages: 1070–1077, Amber M. Bradley, Allison M. Deal, Larry W. Buie and Hendrik van Deventer

    Version of Record online : 3 DEC 2012, DOI: 10.1002/phar.1150

  13. CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients

    Transfusion

    Volume 53, Issue 5, May 2013, Pages: 1024–1032, Ville Varmavuo, Pentti Mäntymaa, Raija Silvennoinen, Tapio Nousiainen, Taru Kuittinen and Esa Jantunen

    Version of Record online : 15 AUG 2012, DOI: 10.1111/j.1537-2995.2012.03848.x

  14. Maintenance treatment in childhood lymphoblastic leukemia

    Evidence-Based Pediatric Oncology

    Ross Pinkerton, Ananth Shankar, Katherine K. Matthay, Pages: 180–197, 2013

    Published Online : 8 MAY 2013, DOI: 10.1002/9781118625309.ch21

  15. You have free access to this content
    Economic Analysis of Prophylactic Pegfilgrastim in Adult Cancer Patients Receiving Chemotherapy

    Value in Health

    Volume 11, Issue 2, March/April 2008, Pages: 172–179, Adi Eldar-Lissai, Leon E. Cosler, Eva Culakova and Gary H. Lyman

    Version of Record online : 21 JUL 2007, DOI: 10.1111/j.1524-4733.2007.00242.x

  16. Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia

    European Journal of Haematology

    Volume 88, Issue 5, May 2012, Pages: 416–421, Prahlad Ho, Peter Sherman and Andrew Grigg

    Version of Record online : 27 FEB 2012, DOI: 10.1111/j.1600-0609.2012.01763.x

  17. Scientific

    Transfusion

    Volume 46, Issue 9s, September 2006, Pages: 1A–164A,

    Version of Record online : 31 AUG 2006, DOI: 10.1111/j.1537-2995.2006.01023_1.x

  18. A pharmacokinetic model of filgrastim and pegfilgrastim application in normal mice and those with cyclophosphamide-induced granulocytopaenia

    Cell Proliferation

    Volume 42, Issue 6, December 2009, Pages: 813–822, M. Scholz, M. Ackermann, C. Engel, F. Emmrich, M. Loeffler and M. Kamprad

    Version of Record online : 17 AUG 2009, DOI: 10.1111/j.1365-2184.2009.00638.x

  19. Prophylactic Use of Antimicrobial Agents, and Antimicrobial Chemotherapy for the Neutropenic Patient

    Antimicrobial Therapy in Veterinary Medicine, Fifth Edition

    Steeve Giguère,, Anthony C.G Abrams-Ogg, Stephen A. Kruth, Pages: 357–378, 2013

    Published Online : 16 AUG 2013, DOI: 10.1002/9781118675014.ch21

  20. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients

    Intervention Review

    The Cochrane Library

    Peter Renner, Stefania Milazzo, Jian Ping Liu, Marcel Zwahlen, Josef Birkmann and Markus Horneber

    Published Online : 17 OCT 2012, DOI: 10.1002/14651858.CD007913.pub2